// App-Quantinova.ai

5425 : Results from the SPARTAN study

Researchers

Presenter

  • Clemente Aguilar

Principal Investigators

  • Michael Gormley

  • Shibu Thomas

  • Paul N. Mainwaring

  • David Olmos

  • Fred Saad

  • Simon Chowdhury

  • Elai Davicioni

  • Yang Liu

  • Deborah S. Ricci

  • Angela Lopez-Gitlitz

  • Margaret K. Yu

  • Matthew R. Smith

  • Eric J. Small

  • Felix Feng

Medical Centers

  • Janssen Research and Development, LLC, Spring House, PA

  • Centre for Personalized Nanomedicine, University of Queensland, Brisbane, Australia

  • Spanish National Cancer Research Centre (CNIO), Madrid and Hospitales Universitarios Virgen de la Victoria y Regional, Institute of Biomedical Research in Malaga, Malaga, Spain

  • Centre Hospitalier de lUniversite de Montreal/CRCHUM, University of Montreal, Montreal, QC, Canada

  • Guys, Kings and St. Thomas Hospitals, and Sarah Cannon Research Institute, London, United Kingdom

  • Meditope Biosciences, Inc., San Diego, CA

  • Janssen Research & Development, Los Angeles, CA

  • Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA

  • Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA

Locations

  • United States

  • Australia

  • Spain

  • Canada

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Prostate cancer

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved